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The BCL-2 family of proteins tightly regulates the delicate balance between life and death. The 
pore forming Bax is a pro-apoptotic member belonging to this protein family. At the onset of 
apoptosis, monomeric cytoplasmic Bax translocates to the outer mitochondrial membrane, forms 
oligomeric pores thereby letting mitochondrial cytochrome c enter the cytosol and initiate the 
apoptotic cascade. The C-terminal “helix 9” is thought to mediate the membrane binding of 
BAX. A 20-amino acid peptide corresponding to Bax C-terminus 
(VTIFVAGVLTASLTIWKKMG) and two mutants where the two lysines are replaced with Glu 
(charge reversal mutant, EE) or Leu (charge neutralization mutant, LL) have been studied to 
elucidate the pore formation capabilities of Bax C-terminus and the underlying molecular 
mechanism. Interactions of the wild-type and the two mutant peptides with zwitterionic and 
anionic phospholipid membranes caused efficient membrane permeabilization, as documented by 
release of vesicle-entrapped fluorescent indicator calcein. Light scattering experiments showed 
that vesicles maintained their integrity upon peptide binding, indicating that the content leakage 
was due to pore formation and not vesicle degradation. Kinetics of calcein release at various 
peptide concentrations were used to determine the peptide-peptide association constants and the 
oligomeric state of the pore.  
The structure of membrane-bound peptides was analyzed by circular dichroism (CD) and 
attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy. CD data 
indicated all three peptides reconstituted in lipid vesicles contained α-helical and β-strand 
structures. ATR-FTIR experiments indicated that the minimally hydrated samples of peptides in 
stacked lipid bilayers (absence of bulk water) were mostly α-helical but adopted mostly β-sheet 
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conformation in the presence of excess water.  
Finally, the depth of membrane insertion of the peptides was analyzed using tryptophan 
fluorescence quenching by dibromo-phosphatidylcholines brominated at various positions of 
their acyl chains. In case of zwitterionc phospholipid membranes, the single Trp
16
 was located at 
~9 Å from membrane center. In case of membranes containing 30% of an anionic phospholipid, 
the depth of membrane insertion of the EE mutant was not affected but the wild-type and the LL 
mutant peptides were embedded much deeper into the membrane, with Trp
16
 located at 3-4 Å 
from membrane center.  
These results will help achieve a better understanding of the molecular mechanism of membrane 
pore formation of Bax protein. In addition, they provide insight into the molecular details of 
membrane pore formation by peptides and could facilitate the design and production of cytotoxic 
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Nature has an on-going balanced phenomenon called Apoptosis, which primarily is the key 
player in controlling several important processes in the body including maintenance of tissue 
homeostasis and normal development. Apoptosis, also called programmed cell death participates 
in homeostasis and removes any defective cells (Mancinelli, Caraglia, Budillon, Abbruzzese, & 
Bismuto, 2006) and is a highly regulated process involving several different pathways and 
millions of proteins working in perfect coordination. 
The mechanism that dictates apoptosis is highly complex. As we mentioned, it consists of a large 
number of proteins which in turn participate in several mechanisms for signaling, commitment 
and execution of apoptosis via numerous simultaneous pathways (Yu & Zhang, 2004). So when 
a cell is committed to die, it attains very distinct phenotypic characteristics, such as blebbing, 
destruction of nuclear material by condensation of chromatin. The end result is many small 
apoptotic bodies that can be engulfed by macrophages. All this is to ensure that only the cell in 
which apoptotic stimulus is generated is affected and all other cells in the vicinity are protected. 
In case if there is a malfunctioning in the apoptotic machinery, the result can be disastrous, such 
as uncontrolled cell growth found in many diseases. These defective cells survive to collect 
further mutations and can even grow under hypoxia and oxidative stress. Conversely, in several 
neurodegenerative diseases such as Huntington's, Parkinson‟s or Alzheimer's disease, there has 
been shown death of selective neurons which can result in loss of memory and involuntary 
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muscle movements. There are two commonly observed pathways which induce cell death signals 
leading to Apoptosis: extrinsic or intrinsic. The  extrinsic pathway is initiated by the formation of 
death-inducing signaling complex (DISC), and intrinsic pathway where an internal signal 
activates Bax, which then translocates to the mitochondria, releasing cytochrome c, propagating 
the caspase cascade (Ashkenazi, 2002). 
 
1.2 BCL Associated X-protein 
 
Bax is a member of the BCL-2 family. The BCL-2 family members are known to be pro and 
anti-apoptotic proteins which participate in various cell functions. During the apoptotic signal, 
Bax inserts itself on the outer mitochondrial membrane, causing membrane destruction and 
permeabilization. This results in release of the contents from the inside of the mitochondria into 
the cytosol. Several studies have been performed where Bax structure and its sub cellular 
location were determined. Cytochrome c associates with Apaf-1 and Procaspase 9 forming 
apoptosome, which in turn degrades all internal proteins (Gogvadze, Orrenius, & Zhivotovsky, 
2006). All this happens by an antagonistic relationship between the pro and anti-apoptotic 
proteins in the Bcl-2 family.  
As far as the structural similarities go in various Bcl-2 family members, it has been found that 
each member has one or more „Bcl-2 Homology‟ regions. Bax contains 9 α-helices and 3 out of 
the four of the BH regions (Reed, 2006). The NMR structure of Bax shows two hydrophobic α-
helices hidden from the aqueous phase by seven amphipathic α-helices (Suzuki et. al, 2000). A 
hydrophobic cleft can be found that is thought to be where the BH3 domains of the Bax and Bak 
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interact (Veresov & Davidovskii, 2009). The Three dimensional backbone structures of Bax, 
BCL-2 and BCL-xL can be superimposed on each other (Suzuki, Youle, & Tjandra, 2000). It is 
only the α9 helix that sits in the hydrophobic pocket and participates in the heterodimer 
formation with its antagonist. Because of the apparent significance of Bax‟s C-terminal α9-helix, 
this project deals with studying its structure and function, i.e., elucidation of pore forming 









Lipid vesicles were used to model the interaction of Bax C-terminal α-helix with membranes 
(Kuwana et al., 2002). Additionally, Bak, another pro-apoptotic BCL-2 family member was 
shown to have its secondary structure modified by the composition of lipid membrane. But it is 
still unknown whether the 9 helix acts as a protein anchor or is itself a participant in pore 
formation.  
The focus of this project was on demonstration that the C-terminal α-9 helix of Bax-C, when 
isolated from the protein as an individual peptide, can form pores in lipid membranes, and 
identification of the biophysical characteristics of the pore, such as the peptide structure, peptide-
peptide affinities within the membrane, and the oligomeric state of the pore.   
We used circular dichroism (CD), Fourier transform infrared (FTIR) spectroscopy and 
fluorescence methods to determine the mode of interaction of Bax-C with membranes and pore 
formation. The effect of membrane electrostatics on peptide-membrane interactions was probed 
by using zwitterionic membranes composed of 100% 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC), and membranes composed of 70% POPC and 30% of an anionic lipid 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG). To probe the importance of the 
double lysine residues near the C-terminus of the -9 helix of Bax, in parallel to the wild-type 
peptide two mutants have been studied where the two lysines were replaced with Glu (charge 




















                                      
Figure 2: The NMR structure of BAX (Suzuki et al., 2000). Helices are colored red, and the C-




1.3 Bax Oligomerization and Localization 
 
Based on previous studies, we have tested the working hypothesis that key mitochondrial 
targeting elements reside in Bax‟s C-terminus. We have examined a putative membrane- binding 
stretch of Bax, i.e., the C-terminal helix that contains double lysines at positions 189 and 190 
(Petros, Olejniczak, & Fesik, 2004; Reed, 2006). The same biophysical techniques like FTIR and 
CD were used to define the parameters of membrane insertion using synthetic membranes in the 














Figure 3: C-terminal helix 9 of Bax is shown with residues Trp 16 and Lys 17, 18 highlighted in 
yellow and blue, respectively (Suzuki et al., 2000). 
 
 
1.4 Objective of the project 
 
The main objective of this project was to test the hypothesis that the α-9 helix of Bax has 
membrane binding and pore forming capability and identify the molecular and structural basis of 
pore formation. Vesicle content leakage and biophysical studies have been carried out using 
synthetic peptide with the sequence (VTIFVAGVLTASLTIWKKMG), which corresponds to the 
last 20 amino acids of Bax to accomplish this objective. The contribution of the two lysine 
residues to the structure and membrane permeabilization activity of the peptide was studied by 
using two mutants of the synthetic 20-mer peptide where the lysines were replaced with either 
glutamic acid or leucine residues.  The effect of membrane charge was evaluated by using 
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zwitterionic POPC membranes as well as membranes containing 70% POPC and 30% of an 
anionic lipid POPG. These studies were aimed at achieving a molecular model of the membrane 
pores made by the Bax C-terminal peptide, which would have a two-fold impact. First, 
identification of the mode of membrane binding and membrane permeabilization by the peptide 
would provide molecular insight into the mechanism of action of Bax on mitochondrial 
membranes. Second, analysis of the structure and pore forming activities of the wild-type and 
mutant peptides would open new possibilities for design and production of potential cytotoxic 





CHAPTER 2. LITERATURE REVIEW 
 
2.1 Are there Bax receptors in OMM? 
 
With the induction of apoptotic stimuli, Bax translocates to the Outer Mitochondrial Membrane 
(OMM) from the cytosolic environment with the aim of permeabilizing OMM.  Due to this, all 
other cellular structures maintain their integrity at the beginning of apoptosis and only Bax 
functions at this time. If this is not true, then the cell would become necrotic leading to complete 
disassociation of the entire cellular environment. Hence, the reason for Bax to go first and bind 
specifically to the OMM is because of the type of lipids along with membrane bound proteins 
which can be classified as either membrane bound proteins with a single or multiple α-helical 
transmembrane domains or proteins with predominant β-structure (Ott, Norberg, Zhivotovsky, & 
Orrenius, 2009). Bax falls in the first category and carries a positive charge with an isoelectric 
point of 10.5, facing the intermembrane space, which is a characteristic of several other single 
membrane spanning proteins (Martínez-Senac, Corbalán-García, & Gómez-Fernández, 2002). 
OMM has a distinct lipid composition, in that cardiolipin is present in mitochondrial membranes 
at significant quantities. Cardiolipin binds cytochrome c, which is found in the mitochindrial 
matrix. This interaction controls the degree of cytochrome c demonstrating that apoptosis is a 
highly regulated phenomenon. It has also been shown that cardiolipin is a receptor for 
Procaspase 8, another apoptotic regulator (Garcia-Saez, Fuertes, Suckale, & Salgado, 2010; 
Gogvadze et al., 2006; Lovell et al., 2008). Strong evidences have been provided for 
mitochondrial targeting of tBid and Bax to the outer membrane of other cellular organelles. 
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However there is a very little cardiolipin (roughly 0.3-1.4%) found in the OMM but often 
researchers are using 10-40% of cardiolipin which strongly exceeds the amount in OMM to 
answer the questions about the presence of receptors. An integral protein of OMM- VDAC, 
forms complexes BCL-2 family proteins Bax, Bak, and tBid and is considered as a “receptor” for 
these proteins (Zeth et al, 2010). However, no strong evidence has yet been provided for the 
existence of specific Bax receptors. 
 
2.2 Knowledge about Bax structure and function 
 
2.2.1 Current knowledge about Bax 
 
Even though several studies have shown that mitochondrial translocation of Bax causes the up 
regulation of Ca
2+
stores with its association with pro-apoptotic proteins, the accurate mechanism 
of Bax is still unknown (Zong et al., 2003). Out of the several studies performed on Bax over the 
years, one suggests that Bax permeabilization of the OMM is due to the similarity in structure 
between the multi domains of BCL-2 family with diphtheria toxin, which forms protein-
translocating pores in the endosomal membrane (Yip & Reed, 2008). Another study suggests that 
upon Bax binding, fragmentation of mitochondria takes place (Karbowski & Youle, 2003). Even 
with these studies, the molecular determinants of binding of Bax to the mitochondrial membrane, 
the pore structure and its oligomeric state remain elusive. Protein-protein interactions have been 
experimentally studied to elucidate the translocation mechanism and its mode of action. A very 
commonly used assay system, called Yeast two-hybrid system was established (Willis et al., 
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2005). It is thought that Bax self associates through BH1 and BH2 domains. If there is any 
anomaly in the heterodimers, then the cell becomes more susceptible to apoptosis. 
Apart from BLC-2 family of proteins, several other signaling pathway proteins also contibute to 
the regulation of Bax. Important among those is a serine threonine kinase called AKT which 
inhibits structural change within Bax, which may inhibit mitochindrial binding, preventing 
apoptosis (Brunet et al., 1999). Since no regulatory changes have been observed in the Bax 
phosphorylation, the mechanism of AKT inhibition is still not clear. In human keratinocytes, on 
the other hand, UVB activation of p38 MAP Kinase promotes the movement of Bax to 
mitochondria. Several upstream effector proteins also modulate the activity of Bax but even with 
these theories, the actual mechanism for the membrane translocation is still unclear (Reed, 2006; 
Torrecillas et al., 2005). 
 
2.2.2 Gap in knowledge about Bax 
 
While previous research in the BAX field has given enormous information about the regulation 
and mechanism of BAX, the key players in its activation have not been identified. Even the 
recent structural studies are somewhat contradictory and do not reveal the mechanism of Bax 
activation. One study suggests that the C-terminal domain is the major component in the protein 
responsible for membrane insertion while the other study proposed that the amino terminal acts a 
mitochondrial targeting sequence (Karbowski & Youle, 2003; Zong et al., 2003).Yet another 
study comes across as a contradictory to the two previous studies and suggests that the pivotal 
role of the N-terminal domain is the commitment to apoptosis (Gogvadze et al, 2006). The role 
of Bax α-9 helix segment has also been suggested as a transmembrane domain that could 
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translocate BAX to the OMM (Ausili et al. 2008). So due to these ambiguous results, there is a 
strong need to gather well defined structural data which focuses on the mechanism of activation 
and function of Bax with respect to the lipid membrane binding. In order to fill this gap, more 
work needs to be performed to determine the critical membrane binding domains in the BAX 
structure and also its intermolecular and intra molecular interactions (Tschammer, 2007).  
 
2.3 Analysis of Protein−Lipid Systems by ATR-FTIR Spectroscopy 
 
In an attenuated total reflection- Fourier transformed infrared (ATR-FTIR) experiments, an 
internal reflection plate made of high quality Germanium is used to deposit the peptide on its 
surface (Tatulian et al., 1995).  A thin layer of lipid containing the reconstituted peptide is 
deposited and an infrared beam is directed onto the plate. The beam undergoes several internal 
reflections from one end of the plate to another, leading to an exponentially decaying evanescent 
field at both surfaces of the Ge plate. Because energy is transferred from the evanescent field to 
the deposited layer of lipid and peptide, a distinct absorption spectrum will be generated which 
carries a plethora of structural information for both the lipid and protein (of peptide) molecules. 
FTIR spectroscopy is very sensitive to protein conformational changes and is not limited to the 
molecular size of the sample (Jackson & Mantsch, 1995). Another advantage of using ATR-
FTIR for peptide structure determination is due to absence of light scattering problems unlike 
circular dichroism or fluorescence experiments in the UV region.  ATR-FTIR is unique in that 
the spectrum of any protein-lipid combination does not require any labeling and generates well-
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resolved absorbance bands for both lipids and proteins and also for various structural groups of 
these protein molecules (Goormaghtigh et al., 1990; Tatulian et al., 1995).  
Secondary structure of proteins can be elucidated by amide I absorption frequencies which is 
generated by the contributions from the C=O (80%) and C-N vibrational stretching found 
between 1600 to 1700 cm
-1
. The particular characteristics of the structural components that make 
up the amide I mode can be used to calculate the proportion of a protein‟s secondary structure 
(different secondary structures generate amide I vibration at distinct frequencies) (Tamm & 
Tatulian, 1993). N-H bending (60%) and C-N stretching (40%) contribute to the amide II band, 
and is found between 1520 to 1580 cm
-1
. It is perhaps the most useful spectral range in 





Table 1: Amide I Frequencies of Most Typical Secondary Structural Elements in Proteins in H2O 
and D2O Environments (Tatulian, 2003). 
 
                           frequency(cm-1) 
Secondary structure  H2O D2O  
αI-helix  1658−1650  1655−1646  
αII-helix  1666−1658  1658−1652  
310-helix  1670−1660  1670−1660  
↑↓β-sheet  1638−1632  1636−1630  
↑↓β-sheet  1695−1675  1680−1670  
Intermolecular β-sheet  1625−1615  1625−1615  
β-turns  1685−1655  1675−1640  
γ-turns  1690−1650  1690−1650  
irregular  1660−1652  1648−1640  
Amide or aromatic side 
chains  
1618−1605  1615−1600 
 
 
2.4 Lipid Monolayers and Bilayers 
 
Several models have been established to study the cellular membranes which will mimic the 
natural environment inside the cell (Liu & Regen, 1993).  For this purpose, lipid vesicles have 
been used as model membranes which will allow the study of protein interaction with the 
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mitochondrial membrane (Frey & Tamm, 1991). One very commonly used method for 
deposition of lipid on the solid surface would be direct spreading but this method has the 
limitation since not all the protein can be uniformly distributed across the area of the Ge plate. 
Other than that the dry protein-lipid solution is believed to be far from the physiological state of 
the actual cellular environment (Fa et al., 2006). Real physiological condition can be modeled to 
a greater amount in comparison to the systems where dried lipid samples are deposited. 
 
 
Figure 4: Creating of Large Unilameller Vesicles using extruder (left) and POPC LUV is created 
by passing through 100 nm pore size membrane 15-20 times (right). (Courtesy Avanti Polar 
Lipids, Alabaster, AL)  
 
Langmuir-Blodgett (LB) technique is used to deposit the lipid monolayer on the Ge plate. In 
order to create a lipid bilayer, lipid vesicles containing peptide are injected into the ATR cells so 
that the peptide-lipid vesicle suspension gets deposited on top of the already coated monolayer. 
The vesicles have been prepared by sonication and are 30-50 nm in diameter. Once the bilayer is 
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created, secondary structure can be determined using spectral measurements obtained at two 
different polarizations of the incident light (Jackson, Haris, & Chapman, 1989). 
 
2.5 Circular Dichroism (CD) 
 
We used Circular Dichroism (CD), a well known method for protein secondary structure 
determination (Brenner et. al, 2000) as a complementary method to FTIR. The asymmetry of the 
-carbon backbones of proteins result in chirality leading to optical activity. This optical activity 
can be useful for the study of α helices or -sheets which constitute large fractions of most 
proteins. Secondary structure determination from CD is done using a number of modeling 
techniques.  
CD spectra are composed of the difference in the absorption of plane polarized light, which has 
been resolved into its left and right handed components. The following equation is used: 
Δɛ = ɛL - ɛR 
Where ɛ is the molar extinction coefficient for either the left (L) or right (R) vectors, 
respectively. The emerging beam is elliptically polarized (Fu et al., 1998). CD spectrum for each 
type of secondary structure is different and hence is a characteristic feature of each secondary 
structure. The spectrum for an α helix has two minima at 208 nm and 222 nm, β- sheets only give 
one minima at 215 nm. The spectrum of unordered structures has a weak maximum around 220 




























1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC), dodecylphosphocholine (DPC), 1-
palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) and brominated lipids were purchased from 
Avanti Polar Lipids, Inc. Alabaster, AL. Bax peptides (Ac-VTIFVAGVLTASLTIWKKMG-
NH2) along with two other mutants were from Biopeptide San Diego, CA. Sephadex
®
 G-50 
medium was  from Amersham Biosciences (Uppsala, Sweden) and SM-2 Biobeads from Bio-
Rad Laboratories (Hercules, CA). Analytical and highest purity chemicals from Sigma 
Aldrich Co. (St. Louis, MO). Calcein disodium salt from Fluka Analytical, Sigma Aldrich 
(St. Louis, MO) while polycarbonate filters for LUV preparation were purchased from 
Avastin, Inc. (Ottawa, Ontario, Canada). 
 
3.2 Calcein Release Assay 
 
Large Unilamellar Vesicles (LUVs), a model membrane system, were generated from a 10 
mM suspension of a lipid mixture as described above. Dried lipid film was suspended in 10 
mM calcein disodium salt in buffer and the mixture was then extruded through a pair of 200 
nm polycarbonate filters 15 times (Rabzelj et al., 2008). Free calcein was removed from the 
calcein entrapped vesicles using Sephadex
TM
 G-50 column. The buffer flow rate was 
maintained at 3 mL/min using Econo Pump (BioRad, Hercules CA) and calcein-loaded 
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vesicle fraction was collected. 150 µM solutions of all three peptide samples (Bax-KK, Bax-
LL and Bax-EE) are prepared (Kaushik, Krishnan, Prausnitz, & Ludovice, 2001) in 6 mM 
DPC using 20 mM phosphate buffer, pH 7.2, containing 0.8 mM EGTA and 150 mM NaCl. 
The peptide/DPC sample was then diluted 10 times by adding to the calcein loaded vesicles 
to make it below its CMC (Fu & Singh, 1999). The increase in fluorescence due to calcein 
release from LUVs was measured between 500-550 nm (λmax =513 nm) with an excitation 
wavelength of 490 nm on Jasco 810 spectropolarimeter at 37
o
C every 20 s for 30 min 
(Bensikaddour et al., 2008; Fu, Lomneth, Cai, & Singh, 1998). Only calcein that leaked from 
vesicles emitted measurable fluorescence because calcein at high concentration within 
vesicles (i.e., 10 mM) self quenches (Fu and Singh, 1999). The minimum and maximum 
(100% leakage) fluorescence intensity corresponding to addition of pure DPC (0.6 mM) and 
0.05% Triton X-100 to the vesicle sample was determined respectively (Lovell et al., 2008; 
Martínez-Senac et al., 2002). 
 
3.3 Circular Dichroism and Fluorescence measurements 
 
 CD and fluorescence spectra of membrane-reconstituted peptides were measured using a J-810 
spectrofluoropolarimeter (Jasco Corp., Tokyo, Japan), as described (Qin et al., 2004; Pande et al. 
2006). In both cases, a 0.4 cm path-length rectangular quartz cuvette containing a magnetic stir 
bar and mounted in the temperature-controlled sample holder was used. For CD measurements, 
LUVs were prepared using pure POPC or a 7:3 combination of POPC/POPG, without Br2PC. 
Tryptophan fluorescence of the peptides was monitored using excitation at 290 nm. The 
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excitation and emission slits were 4 nm and 10 nm, respectively. For CD and fluorescence 
measurements, 10 and 5 scans were co-added to obtain the average spectra. Measurements were 




C as indicated. 
 
3.4 ATR-FTIR Spectroscopy 
 
3.4.1 Sample Preparation 
 
Lipid-peptide samples for ATR-FTIR experiments were prepared using previously described 
methods (Goormaghtigh, 1999; Vigano et al., 2003) with slight modifications. Two µL of the 
peptide dissolved in DMSO at 12.5 mM was dried with compressed nitrogen and by desiccation. 
The dry sample was dissolved in ~20 L of hexafluropropanol, and 125 µL of 10 mM lipid 
dissolved in CHCl3 was added. The peptide-lipid solution at lipid-to-peptide molar ratio of 50:1 
was carefully spread onto one surface of a ~7 cm
2
 clean germanium plate with 45
o
 aperture 
angles and dimensions of 5×20.1 cm
3
 (Spectral Systems, Irvington, NY). The sample was dried 
in a desiccator; the germanium plate was assembled in a home-made ATR sample holder, which 
was mounted into the FTIR spectrometer at a position corresponding to a 45
o
 incidence angle.  
This setting corresponds to approximately 20 internal reflections at one side of the plate. The 
thickness of the sample was evaluated to be ~1.6 µm, which is significantly thicker compared 
than the decay length of the evanescent field (~0.3 m). After measurements of the dry sample at 
two polarizations, the germanium plate with the sample was subjected to D2O vapors for 1 hr in a 
confined volume, and the spectra of the D2O-humidified sample were collected. This was 
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followed by injection of a D2O-based buffer (150 mM NaCl, 10mM Hepes, pD 6.8) into the 
ATR cell and additional spectra collected.  
 
3.4.2 IR Spectroscopy 
 
The signal/noise ratio of FTIR spectra was improved with 200 scans on a Bruker Vector 22 
Spectrophotometer, which was purged continuously with dried air (del Mar Martínez-Senac, 
Corbalán-García, & Gómez-Fernández, 2001). The reference spectra were measured using a bare 
germanium plate or a sample prepared using plane lipid without any peptide. Atmospheric water 
humidity spectra were measured at both polarizations by collecting spectra at various times, 
using the bare germanium plate, and were used for clearing the sample spectra from noise 










Figure 6: Internal Reflection of the infrared light within Ge plate creating an evanescent field at 




3.5 Membrane Insertion 
 
LUV preparation: 100% POPC and 70% POPC and 30% POPG at 10 mM final concentration in 
chloroform. For each of the samples, 10 mol % of 6,7- 9,10- and 11,12- brominated lipids are 
also added to make the total lipid concentration of 1.2 mM (Bensikaddour et al., 2008). 
Chloroform was removed by evaporation with compressed nitrogen followed by vacuum 
desiccation for 1 hr. The lipid film was suspended in 0.5 mL of 20 mM phosphate buffer in H2O, 
pH 7.2, containing 0.8 mM EGTA. LUVs are extruded by passing the lipid solution through the 
extruder with two 100 nm pore size filters and performing the extrusion 15 times to achieve the 
uniform vesicles (Ray, Scott, & Tatulian, 2007). 0.3 mM of peptide sample (Bax-KK, Bax-LL 
and Bax-EE) is taken from the stock in DMSO, solvent is removed under the stream of N2 and 
vacuum desiccated again for 2 hrs. 9 mM DPC is added along with hexafluoroisopropanol 
(HFIP) to dissolve the peptides. The solvent again is removed by a stream of N2 and suspended 
in 32 µL of 20 mM phosphate buffer (Rodionova et al., 1995). DPC is removed by vortexing the 
sample with SM-2 Biobeads (10% by weight) for 2 hrs.10 fold dilution of peptide/DPC sample is 
done in the vesicles so that it goes well below CMC (~1.5mM). Both CD and fluorescence with 









CHAPTER 4. RESULTS 
 
4.1 Calcein Release Assay 
 
Studies on peptide-mediated calcein release from phospholipid vesicles are being conducted 
to see if the wild type and/or the mutant peptides are able to cause membrane destabilization 
and content release. Colum chromatography is performed using Sephadex
®
 G-50 column, a 



















 Scattering at 550nm
 Fluorescence at 490nm
 
Figure 7: Fraction collection for 1 mM calcein-loaded-POPC vesicles using G-50 column at 
25
o
C using 20 mM phosphate buffer containing 0.8 mM EGTA and 150 mM NaCl, pH 7.2 
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4.1.1 Calcein Release Assay with 100% POPC vesicles 
 
Figure 8: Bax mediated calcein release from POPC vesicles demonstrating differences in 
fluorescence intensity. Emission is measured between 500- 560 nm. Maximum intensity is seen 
at 513 nm. 0.05% Triton X-100 is used as positive control. 
 
Figure 9: Fluorescence kinetics of entrapped 10 mM calcein release from vesicles prepared from 
1 mM of POPC in 20 mM Phosphate buffer, pH 7.2. (Blue-Bax KK, Green: Bax-EE, Black: Bax 
LL, Red- Triton, Purple-DPC) 
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4.1.2 Calcein Release Assay with 70% POPC and 30% POPG 
 
 
Figure 10: Bax mediated calcein release from 70% POPC + 30% POPG vesicles demonstrating 
differences in fluorescence intensity. Emission is measured between 500-560 nm. Maximum 
intensity is seen at 513 nm. 0.05% Triton X-100 is used as positive control. 
 
Figure 11: Fluorescence kinetics of entrapped 10 mM calcein release from vesicles prepared 
from 1 mM of POPC in 20 mM Phosphate buffer, pH 7.2. (Blue-Bax KK, Green: Bax-EE, 
Black: Bax LL, Red- Triton, Purple-DPC) 
25 
 
4.2 Membrane permeabilization by peptides 
 
Calcein fluorescence is self-quenched at concentrations higher than ~1 mM (Rapaport et al., 
1996; Park et al. 2006; Klocek et al. 2009). The concentration-dependence of calcein 
fluorescence is shown in Fig. 12A. If lipid vesicles are loaded with calcein at relatively high 
concentrations, then membrane permeabilization can be detected by calcein release into the large 
external compartment, resulting in calcein dilution, dequenching, and increase in fluorescence 
intensity.  We used lipid vesicles 200 nm in diameter at 0.5 mM total lipid concentration loaded 
with 10 mM calcein. Using 4.0 nm for POPC or POPC/POPG membrane thickness (Vogel et al., 
2000) and 0.68 nm
2
 for cross-sectional area per lipid (Seelig et al., 1993), one can evaluate a 0.31 
% fraction of vesicle-entrapped volume. Upon total disruption of the vesicles, calcein 
concentration in the external volume will increase from zero to ~0.03 mM, which corresponds to 
increase in fluorescence intensity to 1.0-1.1 relative units, as judged from data of Fig. 12A.     
Fig. 12B indicates a rapid increase in calcein fluorescence intensity upon addition of 1.667 µM 
of the wild-type peptide BaxC-KK. To ensure that calcein release from the vesicles was due to 
membrane pore formation rather than membrane disruption, vesicle integrity was estimated by 
right angle static light scattering on a J-810 spectrofluoropolarimeter. When incident light was 
used at 550 nm, slightly red-shifted light scattering from vesicles was detected (Fig. 12C). 
Addition of 1/10
th
 volume of buffer resulted in a ~10% decrease in intensity of scattered light 
due to dilution of the vesicle suspension. Addition of 1/10
th
 volume of plain DPC (at final DPC 
concentration of 0.6 mM) or any of the three peptides solubilized in DPC at final peptide 
concentration of 1.667 µM to15 µM did not result in any additional decrease in light scattering, 
indicating that neither the peptides nor DPC caused vesicle disruption. Triton X-100 caused 
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strong reduction of light scattering. The residual scattering was due to mixed Triton X-100-lipid 

















Figure 12: Calcein release experiments spectra showing (A) Calcein concentration curve, (B) 
increase in Fluorescence upon addition of Bax-KK and (C) Light scattering data pre (closed 
circles), post the addition of buffer (open triangles), the peptides,  or Triton X-100 (rhombs). 
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4.3 Analysis of Pore formation kinetics 
 
Following a previously described formalism for peptide-mediate membrane pore formation, we 
propose that introduction of peptide into LUVs results in rapid insertion of the peptide followed 
by membrane destabilization and a slower process of formation of the final structure of the pore. 
In case of the wild type peptide, the fast and slow components are characterized with time 
constants of 10-30 s and 20-10 min, respectively, which are likely related to these processes. 
Upon membrane binding of the peptides and pore formation, the observed calcein fluorescence 
increases from zero to equilibrium value Feq.  If eventually every peptide contributes to pore 
formation, then the concentration of free peptide at time t, [P]t, can be expressed through the 
total peptide concentration, [P]0, and  fluorescence intensity at time t, Ft, as follows:  







                                                                                                               (1) 
 
Given the hydrophobic nature of the peptides and their poor water solubility, it is reasonable to 
assume that nearly all of the peptide is membrane bound. We use a model of pore formation 
where peptide molecules associate with each other in a stepwise fashion to form an oligomeric 
assembly. If the pore is composed of n  2 peptide molecules, then addition of each molecule can 
be considered a second-order process that is described as follows: 
 
 













. Combination of Eqs. (1) 
and (2) yields: 
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                                                                                                     (3)  
     
Equation (3) indicates that the second-order rate constant of pore formation, ka, can be 
determined as the slope of the time dependence of the term at left-hand side of Eq. (3). Values of 
Feq are tabulated in Table 2. 
 
Generally, a bimolecular process where reactants A and B combine in a complex AB, which then 
either dissociates to A and B or leads to the formation of the final product P, can be describe as 
shown in Scheme 1:  
 
                                                         
                                                              Scheme 1 
Here, ka and kd are the forward and reverse rate constants of complex formation, and kp is the rate 














Two cases can be considered. First, product formation is much faster than complex dissociation 
(kp  >> kd). This leads to: 
k keff a                                                                                                                                     (5) 




                                                                                                                     (6) 
Here, K is the peptide-peptide association constant in units M
-1
. 
The oligomeric state of the pore, i.e. the number of peptide monomers per pore, can be estimated 
using a formalism of reversible aggregation (Nir, Nieva. 2000, Nieva, 2003). This model is 
applicable to general cases when the sample contains j = 1 to S different types of vesicles, such 
as vesicles of different size categories, and each vesicle of type j contains up to Nj peptide 
molecules. If the number of peptides per pore is n, then only vesicles containing peptides i = n to 
Nj (n  i  Nj) will leak. The fraction of leakage reached at t   (Feq, see above) relative to the 
maximum possible leakage (Fmax , caused by vesicle disruption by Triton X-100), is given as: 
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                                                                                                                          (7b) 
 In Eq. (7), Ai,j is the normalized fraction of vesicles of size j that contain i bound peptides, and fj 
is the fraction of encapsulated volume of vesicles of type j normalized relative to the total 
encapsulated volume. Considering that the vesicles used in this work have been extruded through 
membranes of defined pore size (200 nm), only one type of vesicles can be considered, i.e., S = 
1. Furthermore, it is reasonable to assume that all vesicles contain similar numbers of peptides, 
i.e. the average number of peptide molecules per vesicle. Under our experimental conditions 
(total lipid concentration of 0.5 mM and peptide concentrations of 1.667 M, 5.0 M, and 15.0 
M), this number varied between 1180 and 10650, which is much larger than any conceivable 













                                                                                               (8) 
Combination of Eqs. (7) and (8) yields: 
 n 1F q n nq qrel
                                                                                                           (9) 
If experiments of vesicle content release are performed at various peptide concentrations, then 
the experimental values of Frel can be determined at each concentration and compared with those 
calculated through Eq. (9) using different values for n. Values of n at which the calculated and 
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measured values of Frel merge can be used as the number of peptide molecules per pore. It 
should be noted that this procedure of determination of n is more accurate than the model 
considering an irreversible aggregation, in which overestimated values of n are obtained (Parente 
et al, 1990). Furthermore, the calculated value of Frel does not depend on the fraction of 
membrane-bound peptide. If the fraction of membrane-bound peptide decreases x times, the 
slope of the linear relationship given by Eq. (3), and hence ka, and consequently K (Eq. 6) 
increase x times. Thus, in Eq. (7b) a certain change in membrane-bound peptide concentration 
[P]0 is compensated by an opposite change in K, resulting in no change in values of q (Eq. 7a) 
and Frel at a given n. This indicates that using the experimental values of the total peptide 






Table 2: Kinetic parameters of calcein release from vesicles composed of 100% POPC (PC) or 
70% POPC + 30% POPG (PC/PG) derived from fitting the data with a double-exponential 
equation: Ft = Feq – a1exp(-k1t) – a2exp(-k2t), where Ft is calcein fluorescence intensity at time t, 
Feq is the fluroscence at t→∞, k1 and k2 are the rate constants. Cp is the total peptide 









 PC PC/PG PC PC/PG PC PC/PG PC PC/PG PC PC/PG 
                                                                          BaxC-KK 
1.667 0.5622 0.5969 0.2974 0.1917 0.2633 0.3724 0.002939 0.001936 0.086286 0.038464 
5.0 0.6224 0.6312 0.1722 0.2236 0.4508 0.3949 0.002589 0.002632 0.105304 0.050731 
15.0 0.6920 0.6726 0.1555 0.1618 0.5283 0.5078 0.0035407 0.005551 0.074997 0.115064 
                                                                          BaxC-EE 
1.667 0.3811 0.2555 0.1652 0.1175 0.2008 0.1387 0.001164 0.000817 0.000401 0.002029 
5.0 0.5912 0.6078 0.4165 0.4592 0.1784 0.1529 0.001362 0.001256 0.015592 0.008628 
15.0 0.7075 0.7020 0.2238 0.2382 0.4733 0.4596 0.003443 0.003539 0.025874 0.015385 
                                                                           BaxC-LL 
1.667 0.2076 0.3264 0.1244 0.2412 0.07143 0.0784 0.000629 0.001130 0.004593 0.007391 
5.0 0.2781 0.5085 0.2002 0.3918 0.07003 0.1085 0.001035 0.000573 0.017925 0.011937 
15.0 0.3969 0.6134 0.1933 0.2302 0.2013 0.3390 0.001136 0.001239 0.010174 0.000376 
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Now once the double exponential constants are calculated, there is need to evaluate the degree of 
affinity between those peptide molecules. For this purpose the affinity constants are calculate. 




-fold smaller than the estimated value 
of kdiff, indicating that the pore formation is much slower than a simple diffusion-controlled 
process. This in turn implies that in most cases peptides can diffuse away from each other before 
the complex is formed. Thus, the rate constant of peptide complex formation, kp, is the rate-
determining step, and therefore, according to Eq. 6, keff = Kkp. Here, keff is the observed second-
order rate constant, i.e. those summarized in Table 3 as ka1 and ka2, K is the peptide-peptide 
binding constant, and kp is the rate constant of peptide complex formation. Analysis of the 
kinetic data on peptide-induced vesicle content leakage indicates rapid membrane binding of the 
peptide, with time constants in the range of seconds, followed by two distinct processes that can 




 at 5-10 min following peptide 




 at later times (Table 3). The process taking place at earlier 
times likely reflects the nucleation of the pore complex, which is the rate-limiting step of pore 





. The second process is interpreted in terms of formation of the final pore structure, which 
proceeds at a 4-fold higher speed and results in peptide-peptide association with affinity 




 (Table 3).  These results for the mutant peptides fit well with 
the model for initial nucleation of the pore structure, including 2-3 peptide molecules, and further 
progression of the process to the final pore structure that can probably contain a varying number 
of peptide molecules which appears to be limited by of n = 8 molecules per pore (see below for 
more detail on the mechanism of pore formation). 
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Table 3: The fraction of maximum possible vesicle content leakage (Frel), second-order rate 
constants (ka1 and ka2), and peptide-peptide affinity constants (K1 and K2) characterizing 
membrane pore formation by the peptides. Parameters ka1 and K1 were derived from the data for 
initial time period (5-10 min) following addition of peptides to the vesicles, while ka2 and K2 
were derived from data corresponding to later times (~ between 10-20 min).   Cp is the total 
peptide concentration in M.  
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4.4 The Structure of Membrane-Bound Peptides by ATR-FTIR 
 
The peptide sample was mixed with two different lipids and deposited on the Germanium plate. 
The lipid-peptide sample was subjected to three different environmental conditions. Every 
measurement is done at two polarizations of the infrared light with respect to the plate, which are 
used to obtain a polarization independent spectrum as A=A|| + 1.44A┴. This spectrum is then 
processed for second derivative determination and finally curve fitted to evaluate the secondary 
structure determination. All the electric field components of the evanescent field need to be taken 
into consideration (Marsh et al, 1999). The polarized spectra were used to calculate the dichroic 
ratios and then the orientations of membrane-bound peptides. 
Curve fitting is performed for the polarization independent spectra for each of the three cases of 
dry, vaporized and buffer peptide sample. The curve fitting results for ATR-FTIR indicate that 
the minimally hydrated samples of peptides in stacked lipid bilayers (absence of bulk water) 
were mostly α-helical but adopted mostly β-sheet conformation in the presence of excess water. 
Hence a larger peak around ~1627 cm
-1
 is seen in hydrated samples indicating the transformation 







4.4.1 Bax KK 
 
The wild type Bax peptide is first measured using dry lipid film on the Ge plate. Then the sample 
hydrated with D2O vapors and finally flushed with D2O buffer to determine the change in the 
secondary structure upon various environments. Increase in β-sheet structure was identified upon 
exposure of the sample to bulk aqueous phase.  



























Figure 13: ATR-FTIR spectra for Bax KK in 100% POPC (A-C) and 70% POPC and 30% 
POPG (D-F) films deposited on the Ge plate in the absence hydration (A, D), exposed to D2O 
vapor for 1 hr (B, E), and in the presence of bulk D2O-based buffer (C, F). 
 
The dry sample has a greater percentage of helix in its secondary structure (A, D) compared to 
when the sample is hydarated with D2O vapors for an hour (B, E). A greater peak is seen around 
1624 implying an increase in the percentage of β sheets after vaporization. Finally the hydrated 
sample (C, F) have very large β sheets implying more β sheet formation after D2O buffer 
hydration.  
As we can see that an iterative curve fitting between 1700 and 1600 cm
-1
 is a very important tool 
in order to determine the area of amide I components. All the peaks generated during curve 
fitting are based on secondary derivatives and hence closely correspond to various secondary 
structures present in the peptide at that given environmental condition. Three different conditions 
would yield three different ATR-FTIR spectra which were individually curve fitted. Sum of all 
the peaks would give the entire amide I region and is called a „fitted peak‟. Finally the 
percentage of one particular secondary structure present in the peptide can be calculated by 










4.4.2 Bax EE 
 
The mutant Bax EE is also measured using dry lipid film on the Ge plate. Then the sample was 
hydrated with D2O vapor and finally flushed with D2O buffer to determine the change in the 
secondary structure upon various environmental changes. Again, excess water caused the peptide 
to adopt a mostly -sheet conformation. 
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Figure 14: ATR-FTIR spectra for Bax EE in 100% POPC (A-C) and 70% POPC and 30% POPG 
(D-F) films deposited on the Ge plate in the absence hydration (A, D), exposed to D2O vapor for 
1 hr (B, E), and in the presence of bulk D2O-based buffer (C, F). 
 
 
4.4.3 Bax LL 
 
The mutant Bax LL is also measured using dry lipid film on the Ge plate. Then the sample was 
hydrated with D2O and finally flushed with D2O buffer to determine the change in the secondary 














Figure 15: ATR-FTIR spectra for Bax LL in 100% POPC (A-C) and 70% POPC and 30% POPG 
(D-F) films deposited on the Ge plate in the absence hydration (A, D), exposed to D2O vapor for 
1 hr (B, E), and in the presence of bulk D2O-based buffer (C, F). 
Note: Bax LL peptide was rich in β-sheet structure under all conditions. 
 
Table 4: Fractions of alpha helix and beta sheet structures in peptides from ATR-FTIR data 
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4.5 Confirmation by Circular Dichroism 
 
It has now been shown by the ATR-FTIR experiments that Bax peptides assume more -sheet 
confirmation in the presence of bulk water. This idea was confirmed by CD experiments where 
peptides were dissolved in aqueous buffer and readings were taken to study their secondary 
structure. The β-sheets always give a minimum around 215 nm which was a characterizing 







Figure 16: Structural analysis by CD confirming the mostly -sheet secondary structure of Bax 
Peptides. 
4.6 Depth of Membrane Insertion 
Depth of membrane insertion was determined at both 20°C and 37°C by fluroscence quenching 
of Trp by dibromo-phosphatidylcholines (Br2PCs). The effect of membrane charge was studied 
by using pure 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) and 70% POPC + 30% 1-
palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) in membrane preparations with and without 
Br2PCs  brominated at 6,7-, or 9,10-, or 11,12 positions of the acyl chains. 
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4.6.1. Fluorescence Spectra 
 
The depth of membrane insertion was determined as described previously (Ray et al, 2007).  
 
Figure 17: Fluorescence of Bax-KK measured using excitation at 290 nm, at 37
o
C. Pure POPC 
(left) and 70% POPG + 30% POPG (right) are compared using same concentrations of 
brominated lipids. (Blue- Pure Lipid, Orange- 6,7 Br2PC, Green- 9,10 Br2PC, Red- 11,12 Br2PC) 
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Figure 18: Fluorescence of Bax-EE measured using excitation at 290 nm, at 37
o
C. Pure POPC (left) and 
70% POPG + 30% POPG (right) are compared using same concentrations of brominated lipids. (Blue- 










Figure 19: Fluorescence of Bax-LL measured using excitation at 290 nm, at 37
o
C. Pure POPC 
(left) and 70% POPG + 30% POPG (right) are compared using same concentrations of 




4.6.2. Distribution Analysis 
 
“Distribution analysis” of the experimental data was determined by the formulation as shown in 




Where F0 is the fluorescence intensity without and  F the intensity with quencher; S is the area 
and σ the dispersion of the distribution curve; and h is the distance and hm is the most probable 
distance from the membrane center (Ray et al, 2007).  
The final concentration of Bax that was added to the suspension after preparation of the vesicles 
was 30 μM. Lipid and protein concentrations ensured that most of the protein was bound to the 
membranes. Spectra of blank buffer were measured as references and used for correction by 
subtracting from the sample spectra. Samples were thermostated at each temperature for 5 min 
before the spectra were recorded, with constant stirring by a magnetic stir bar in a 0.4 cm path 
length quartz cuvette. The three values of ln (F0/F), which were obtained with three different 
Br2PCs, were plotted as a function of the distance of bromines in Br2PCs from the membrane 
center, i.e., 11.0, 8.3, and 6.5 Å for 6,7-, 9,10-, and 11,12-Br2PC respectively as shown in Fig 20. 





Figure 20: “Distribution analysis” of all three peptides was performed using the equation which 
results in individual fitted curves for pure POPC (A) and with 70% POPG + 30% POPG (B) lipid 
compositions (Blue: Bax-KK, Green: Bax-LL, Red: Bax-EE).  
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CHAPTER 5. DISCUSSION 
 
Insertion of Bax into mitochindrial membrane is the hallmark of Apoptosis. The solution 
structure of Bax has been solved (Torrecillas et al, 2008). However the exact mechanism of 
its function is still unknown. For this reason elucidation of secondary structure and mode of 
insertion becomes most important. With the calcein release experiments, it is established that 
Bax C-terminal peptide is able to form pores in lipid membranes and cause vesicle content 
release. Given the hydrodynamic radius of calcein of 0.64 nm, the pore has a diameter of at 
least 1.3 nm or larger.  Wild type Bax KK has the highest penetration in the lipid vesicles. 
However for pure POPC membranes, Bax LL releases more calcein than vesicles made with 
30% anionic lipids. Once we have established that different peptides have different rupture 
powers for the lipid vesicles, we conducted structural studies to elucidate the molecular basis 
for membrane pore formation by the peptides. Using brominated lipids the position of 
tryptophan is determined and it is seen that for pure POPC membranes, Trp16 is around 9.3 
Å from the membrane center and our results are consistent for all three peptides. However for 
30% POPG, Trp16 was inserted much deeper; hm was seen to be around 2.7 and 5.3 Å for 
wild type and Bax-LL peptides respectively but was at hm  9 Å for the Bax-EE peptide. 
Thus, the wild type Bax peptide has the highest membrane insertion and the strongest 
membrane perforation potency, which may play a role in pore formation in mitochondrial 




Peptides applied to calcein-loaded vesicles resulted in gradual increase in calcein 
fluorescence, apparently induced by membrane permeabilization by the peptides and calcein 
release (Fig. 21). While the kinetics and the level of calcein release were dependant on 
specific peptide, and its molar concentration as well as the lipid composition of vesicle 
membranes. All traces of time-dependence of calcein fluorescence could be fitted with Ft = 
Feq – a1exp(-k1t) – a2exp(-k2t), where Ft  is calcein fluorescence intensity at time t, offset by 
subtraction of the fluorescence before peptide addition,  Feq is the extrapolated level of 
fluorescence at t  , a1 and a2 are the fractions of  the two kinetic components, and  k1 and 





Figure 21: Addition of the peptides to calcein-loaded vesicles resulted in gradual increase in 




Data of Fig. 22 indicate an initial linear time dependence of Feq/{[P]0(Feq – Ft)},characteristic of 
a bimolecular reaction, followed by a second segment of linear dependence with a higher slope at 
t  10 min (for POPC/POPG vesicles and 15 µM peptide the second segments starts earlier). The 
data points corresponding to the second linear segment involve considerable noise because with 
increasing time Ft approaches Feq and the values of Feq/{[P]0(Feq – Ft)}become progressively 
unstable as the denominator decreases. Two linear segments of the graphs indicate that at least 
two processes are involved in membrane pore formation. If membrane binding of the peptide is 
relatively fast, as suggested by the 10-30 s time constant of the fast component of the double-
exponential curves for BaxC-KK, then both linear segments of the graphs of Fig. 22 should be 







Figure 22: Spectra indicate an initial linear time dependence characteristic of a bimolecular 
reaction, followed by a second segment of linear dependence after addition of BaxC-KK peptide 
to the calcein-loaded vesicles. 
50 
 
The final step in characterization of pore formation is evaluation of the oligomeric state of the 
pore. This was achieved using a model of reversible aggregation that has been applied previously 
to describe membrane pores formed by other peptides (Nir, Nieva. 2000, Nieva, 2003). The 
mechanism of pore formation was analyzed using the slower double-exponential rate constants, 
which are believed to reflect the kinetics of pore formation. Fig. 23 indicates that when values of 
ka1 are used, which characterize the pore formation process at earlier times (5-10 min), the 
experimental data for BaxC-KK agree with n  3-4 for POPC membranes (Fig. 23A) and n  2-3 
for POPC/POPG membranes (Fig. 23B). When values of ka2 are used, which characterize further 
progression of pore formation process, the data are consistent with n  8 for POPC membranes 
(Fig. 23C) and n  5 for POPC/POPG membranes (Fig. 23D). Thus, the overall picture of 
membrane pore formation by the wild-type BaxC-KK peptide is that the peptide molecules form 





 followed by a more efficient process (higher 2
nd
 order rate constant) of the 










Figure 23: Figure indicates that when values of ka1 are used, which characterize the pore 
formation process at earlier times (5-10 min), the experimental data for BaxC-KK agree with n~ 
3-4 for POPC membranes (A) and n ~ 2-3 for POPC/POPG membranes (B). When values of ka2 
are used, which characterize further progression of pore formation process, the data are 
consistent with n~ 8 for POPC membranes (C) and n~5 for POPC/POPG membranes (D).  
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Depth of membrane insertion was performed to determine the varying rupturing power of 
different petides in two different lipid compositions. These studies were performed to 
complement our understanding of how these peptides create pores in the membranes and how 
much they differ from each other in their pore forming abilities. Using brominated lipids, the 
position of tryptophan is determined and it is seen that for pure POPC membranes, Trp16 sits at a 
farther distance from the membrane center, both above and below while it got inserted much 
deeper when the lipid was incorporated with 30% POPG. Additionally with 30% POPG 
composition, the insertion ability differs with each mutant and Bax KK was seen to have the 
highest penetration into the membrane while Bax LL showed the least. This is in contrast with 
the pure POPC membranes where all three mutants share almost similar insertion.  From all these 
studies, we conclude that wild type Bax has the highest penetration in the lipid membrane and 
would expedite the release of cytochrome c.  
We have seen that Bax peptide and its mutants penetrate into the lipid membrane and have a 
certain depth of insertion; we are interested in determining the secondary structures for the 
peptide in various environments. As the peptide is exposed more to the buffer, the amount of β 
sheets increase while α helices go down. In the dry sample, more α-helices are seen and in the 
hydrated sample, amount of  sheets increases dramatically. This indicates that the mode of 
action of Bax C-terminal peptide may involve a β barrel-like structure. In conclusion, our studies 
have identified that Bax C-terminal peptide itself has the potency of forming relatively large 
pores in lipid membranes. The wild type peptide with two lysine residues is more potent than the 
charge-reversal or charge neutralization mutant peptides in pore formation. CD and FTIR studies 
indicate that under physiologically relevant conditions, the peptide‟s secondary structure 
53 
 
contains significant fractions of -sheet. Finally, fluorescence quenching experiments identify a 
pattern of membrane insertion of the peptides that is consistent with a -barrel-type structure of 
membrane pores. It should be expected that the behavior of the isolated peptides would be 
different than when it is attached to the protein. However, these findings are encouraging in 
terms of developing cytotoxic peptide-based molecular tools for cell membrane perforation and 
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